[1]
“Intensive Versus Non-intensive Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)”, Can Hematol Today, vol. 4, no. 2, pp. 22–35, Sep. 2025, doi: 10.58931/cht.2025.4273.